Mark Layton

3.0k citations

71 papers · 1.8k indexed · h-index 25

Hematology top 1%
- Acute Myeloid Leukemia Research 6
- Iron Metabolism and Disorders 6
- Blood groups and transfusion 6
Genetics top 2%
- Hemoglobinopathies and Related Disorders 25
Physiology top 1%
- Erythrocyte Function and Pathophysiology 10
Pediatrics, Perinatology and Child Health top 5%
- Neonatal Health and Biochemistry 7
- Prenatal Screening and Diagnostics 7
Immunology top 10%
Infectious Diseases
- Parvovirus B19 Infection Studies 6

Co-authors: Sally Hollis Iain B. McInnes Edward Keystone JW Janssen Herman Van den Berghe H. Heimpel B. Kubanek J Lyons
Cited by: Hematology Genetics Physiology
Journals: Blood (12 papers)British Journal of Haematology (8 papers)The Lancet Rheumatology (3 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Mark Layton

68 papers receiving 1.8k citations

Peers

Countries citing papers authored by Mark Layton

Since Specialization

Citations

This map shows the geographic impact of Mark Layton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Layton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Layton more than expected).

Fields of papers citing papers by Mark Layton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Layton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Layton. The network helps show where Mark Layton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Layton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Layton Line = papers co-authored together Mark Layton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Individual Watershed Areas in Sickle Cell Anemia: An Arterial Spin Labeling Study Frontiers in Physiology ·Yuan Zhaoyuan,Patrick W. Hales,Anna Hood,健田子,Jamie M. Kawadler,Dawn E. Saunders,И. С. Серебряков,David C. Rees,Olu Wilkey,Mark Layton,Lee Howard,Baba Inusa,Jo Howard,Subarna Chakravorty,Chris A. Clark,Fenella J. Kirkham	2022	8
2	Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study The Lancet Rheumatology ·Christopher D. Buckley,Jesus Abraham Simón Campos,Вячеслав Миколайович Ждан,Brandon Becker,Katherine Davy,Elena Fisheleva,蒋继国,HA Hassooni,David R. Inman,Mark Layton,Nina Mitchell,Jatin Patel,Ana Blanco Guada,R. Williamson,Paul P. Tak	2020	24
3	SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt BMJ Open ·R M Molloy,Kofi A. Anie,Jacky B. Buckton,Mun-Seok Jang,Mark Layton,Lo Fai-man Ivan,Claire Hemmaway,Lu Yong,Claire Amos,Caroline J Doré,Brennan C Kahan,Sarah Meredith	2016	4
4	Missense mutations in the perforin (PRF1) gene as a cause of hereditary cancer predisposition OncoImmunology ·Mohammed S. Chaudhry,Kimberly Gilmour,Imran G. House,Mark Layton,Nicki Panoskaltsis,Tita Dede Hari Fitroh Nurjanah,Joseph A. Trapani,Ilia Voskoboinik	2016	17
5	Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine Annals of the Rheumatic Diseases ·Edward Keystone,Jian-Xin Qui,Mark Layton,Sally Hollis,Iain B. McInnes	2012	264
6	Managing the difficult case of fetal anemia The Journal of Maternal-Fetal & Neonatal Medicine ·S. Abreu Ferrer,Fiona Regan,Mark Layton,Winfred Northcott,P. Pankiewicz,Irene Roberts,Sailesh Kumar	2011	3
7	Inherited glycosylphosphatidyl inositol deficiency: A treatable CDG Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·António Almeida,Mark Layton,Anastasios Karadimitris	2009	31
8	Four pedigrees of the cation‐leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na⁺–K⁺ leak in a xerocytic form British Journal of Haematology ·韩有月,Mark Layton,Arun K. Sinha,Lucia Isla Barragan,Bijay Vaidya,V. Connolly,Paul Mannix,Margaret C. Chetty,Anna Nicolaou,Gordon W. Stewart	2004	9
9	Two novel mutations in severe factor VII deficiency British Journal of Haematology ·Keith Gomez,Michael Laffan,Geoffrey Kemball‐Cook,John Pasi,Mark Layton,J.D. Singer,Edward G. D. Tuddenham,John H. McVey	2004	7
10	Role of receptor activator of nuclear factor‐kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1‐alpha (MIP‐1a) in monoclonal gammopathy of undetermined significance (MGUS) British Journal of Haematology ·Marianna Politou,Evangelos Terpos,Αchilles Anagnostopoulos,Richard Szydlo,Michael Laffan,Mark Layton,Jane F. Apperley,Meletios Α. Dimopoulos,Amin Rahemtulla	2004	83
11	Elevated Erythrocyte CDP‐Choline Levels Associated with β‐Thalassaemia in Patients with Transfusion Independent Anaemia Nucleosides Nucleotides & Nucleic Acids ·Arian Laurence,Mark Layton,J. A. Duley,H. Anne Simmonds	2004	1
12	Characteristic changes in erythrocyte nucleotides in haemolytic anaemia with basophilic stippling of differing aetiology Cellular & Molecular Biology Letters ·Arian Laurence,J. A. Duley,H. Anne Simmonds,Mark Layton	1999	4
13	Absence of Expression of the Wiskott–Aldrich Syndrome Protein in Peripheral Blood Cells of Wiskott–Aldrich Syndrome Patients Clinical Immunology and Immunopathology ·Lucy MacCarthy‐Morrogh,H. Bobby Gaspar,Hugo A. Mejías,F Katz,سیدمحمد موسوی جد,Mark Layton,Alison Jones,Christine Kinnon	1998	30
14	Polyarthritis, rash and lymphadenopathy: Case reports of two patients with angioimmunoblastic lymphadenopathy presenting to a rheumatology clinic Clinical Rheumatology ·Mark Layton,Ilaria Blarzino,P. T. Dawes	1998	7
15	Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years BMJ ·B. Modell,Mary Petrou,Mark Layton,Christine Slater,Leslie Müller Pinochet,CH Rodeck,J. Riedlinger,K. H. Nicolaides,Simon Gibbons,Alison Fitches,Julie M. Old	1997	53
16	Metabolic Correction of Triose Phosphate Isomerase Deficiencyin Vitroby Complementation Biochemical and Biophysical Research Communications ·Meesala Navya Deepthi,Ann Humphries,A. J. Bellingham,Mark Layton	1997	9
17	Diagnosing and preventing inherited disease: Detection of sickle gene by coelocentesis in early pregnancy: a new approach to prenatal diagnosis of single gene disorders Human Reproduction ·D. Jurkovic,Eric Jauniaux,S. Campbell,Megan Mitchell,C. Lees,Mark Layton	1995	29
18	Fetal and Maternal Erythropoietin Levels in Normal Pregnancy Fetal Diagnosis and Therapy ·Robin Ireland,A. Abbas,B. Thilaganathan,Yongchao Liao,Filip Ctvrtlik,Mark Layton,K. H. Nicolaides	1992	30
19	Leukemia characterized by multiple sub‐clones with unbalanced translocations involving different telomeric segments: Case report and review of the literature Genes Chromosomes and Cancer ·Barsha Deo,Mark Layton,Lorna M. Secker‐Walker	1990	34
20	ras Gene Mutations and Clonal Analysis Using RFLPs of X-chromosome Genes in Myelodysplastic Syndromes Hämatologie und Bluttransfusion ·Karthik Rao,Michael Buschle,Mark Layton,J Lyons,CR Bartram	1989	1

About Mark Layton

Mark Layton is a scholar working on Hematology, Genetics, Pediatrics, Perinatology and Child Health, Rheumatology and Physiology, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (25 papers), Erythrocyte Function and Pathophysiology (10 papers), Neonatal Health and Biochemistry (7 papers), Prenatal Screening and Diagnostics (7 papers), Acute Myeloid Leukemia Research (6 papers), Parvovirus B19 Infection Studies (6 papers), Iron Metabolism and Disorders (6 papers) and Blood groups and transfusion (6 papers). The work is most often cited by research in Hematology (847 citations), Genetics (562 citations), Physiology (203 citations), Pediatrics, Perinatology and Child Health (332 citations) and Immunology (276 citations). Mark Layton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Sally Hollis, Iain B. McInnes, Edward Keystone, JW Janssen, Herman Van den Berghe, H. Heimpel, B. Kubanek, J Lyons, Michael Buschle and E. Kleihauer. Their work appears in journals such as Blood, British Journal of Haematology, The Lancet Rheumatology, Annals of the Rheumatic Diseases and Journal of Pediatric Gastroenterology and Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact